Bone Marrow TransplantationBone MarrowTransplantation, HomologousHematologic NeoplasmsBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousLeukemiaWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningBone and BonesAnemia, AplasticTransplantation ChimeraTissue DonorsLiver TransplantationGraft SurvivalBusulfanHistocompatibility TestingHistocompatibilityBone Marrow PurgingCyclophosphamideHematopoietic Stem CellsLeukemia, Myeloid, AcuteCombined Modality TherapyTreatment OutcomeRecurrenceTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-HodgkinKidney TransplantationTime FactorsMice, Inbred C57BLRetrospective StudiesLeukemia, MyeloidSurvival AnalysisImmunosuppressive AgentsMyelodysplastic SyndromesRemission InductionLymphomaRadiation ChimeraBone Marrow ExaminationAntineoplastic AgentsNeoplasmsGraft RejectionAcute DiseaseHepatic Veno-Occlusive DiseaseStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsTransplantation ImmunologySurvival RateLymphocyte DepletionLeukocyte TransfusionBone Marrow NeoplasmsBone RemodelingImmunosuppressionMultiple MyelomaHematologic DiseasesT-LymphocytesHLA AntigensGraft vs Host ReactionFollow-Up StudiesLymphocyte TransfusionFlow CytometryPrognosisChimeraHeart TransplantationBreast NeoplasmsCell ProliferationDisease-Free SurvivalActuarial AnalysisColony-Forming Units AssayGraft vs Tumor EffectCell Line, TumorCyclosporineSevere Combined ImmunodeficiencyCord Blood Stem Cell TransplantationMice, Inbred BALB CCell DifferentiationApoptosisLung TransplantationGraft vs Leukemia EffectNuclear FamilyAntibodies, MonoclonalBone DensityHodgkin DiseaseOpportunistic InfectionsLeukocyte CountEtoposideImmunocompromised HostGranulocyte Colony-Stimulating FactorGene Expression Regulation, NeoplasticTumor Cells, CulturedProspective StudiesCytarabineCarmustineMelphalan